Singapore: +65-85097465 | India: +91-40-42023318
  U.S / Canada Toll Free: +1-866-259-4781
  Zimbabwe: +263-735539685, 773876488

          

Clinical Trial News

Inaccurate reporting jeopardising clinical trials

Researchers at The University of Manchester say better method reporting in animal experiments could save hundreds of thousands of pounds and stop clinical trials being commissioned that have no...

Breakthrough in 'editing' mitochondrial disease DNA

High percentages of mutated mitochondrial DNA can lead to severe and incurable diseases. The Salk Institute report success in designing enzymes to 'edit' out this mutated DNA.

EU study to help understand if Intratumoral CD8+ T lymphocytes can predict outcomes in patients with previously untreated stages IIIb to IV melanoma

Amgen has announced the initiation of a clinical trial, NCT02366195, to determine whether baseline CD8+ T lymphocytes density is a biomarker of response to talimogene laherparepvec, an...

Regeneus Ltd receives approval for Progenza osteoarthritis trial

Regeneus, a clinical stage regenerative medicine company focused on the development of cell therapies, announced today that it has received ethics approval for a clinical trial of its new...

UF Health Proton Therapy Institute opens randomized clinical trial for glioblastoma

Adults who have a recent diagnosis of glioblastoma, the most common primary brain tumor, may be eligible to enroll in a national randomized clinical trial at the University of Florida Health Proton...

Parent satisfaction with clinical trial on treating aggressive behavioral disorders

A new study of families participating in a clinical trial to treat children with severe physical aggression explored the factors affecting parent satisfaction with the research study.

New study will test if anti-amyloid antibody can prevent development of Alzheimer's disease

Researchers at the University of Pittsburgh School of Medicine will be part of a multicenter trial that will test for the first time whether a drug that treats brain plaques can prevent later...

Low serotonin is mythical cause of depression, says psychiatry professor

The commercial success of SSRI antidepressants is based on a ‘myth’ that has been a 'costly distraction' from better treatment approaches, suggests one expert.



James Lind Institute Newsletter
James Lind Institute Linkedin
James Lind Institute RSS
James Lind Institute Email Update
James Lind Institute Blog
James Lind Institute Facebook